Multicenter, retrospective population-based study on the incidence of medication-related osteonecrosis of the jaw in patients with breast cancer with bone metastases.

MLA

Brunner, Christine, et al. “Multicenter, Retrospective Population-Based Study on the Incidence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer with Bone Metastases.” Journal of Clinical Oncology, vol. 41, June 2023, p. 6588. EBSCOhost, https://doi.org/10.1200/JCO.2023.41.16_suppl.6588.

APA

Brunner, C., Marth, C., Egle, D., Ritter, M., Baumgart, F., Emmelheinz, M. E., Walch, B., Iannetti, C., Zabernigg, A., Castellan, M., Andraschofsky, O. T., Markl, A., Hubalek, M., Schnallinger, M., Woell, E., Puntscher, S., Arvandi, M., Siebert, U., Bruckmoser, E., & Laimer, J. (2023). Multicenter, retrospective population-based study on the incidence of medication-related osteonecrosis of the jaw in patients with breast cancer with bone metastases. Journal of Clinical Oncology, 41, 6588. https://doi.org/10.1200/JCO.2023.41.16_suppl.6588

Chicago

Brunner, Christine, Christian Marth, Daniel Egle, Magdalena Ritter, Florentina Baumgart, Miriam Elisabeth Emmelheinz, Benjamin Walch, et al. 2023. “Multicenter, Retrospective Population-Based Study on the Incidence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer with Bone Metastases.” Journal of Clinical Oncology 41 (June): 6588. doi:10.1200/JCO.2023.41.16_suppl.6588.